System1 (SST) stock was 43% lower pre-bell Friday after the company announced a plan to delist from the New York Stock Exchange voluntarily.
Oragenics (OGEN) shares were down 42% after the company posted financial results for the quarter ended Sept. 30.
NeuroPace (NPCE) stock was 39% lower after the company posted lower-than-expected Q3 sales and cut its fiscal 2026 revenue outlook.
Candel Therapeutics (CADL) shares were 32% lower after the company reported a wider Q3 loss.
Algorhythm (RIME) stock was down 27%, partially reversing the 65% rise in the prior session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments